The aim of the study is to optimize therapy of migraine patients, according to the Dutch GP Guideline for headache and consequently reduce the use of triptans. The project will explore the costs and effects of a proactive approach of patients with…
ID
Bron
Verkorte titel
Aandoening
migraine
Ondersteuning
Stichting Nuts Ohra
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
HIT-6 (Headache Impact Test)-score at baseline and after 3, 6, 9 and 12 months.
Achtergrond van het onderzoek
We aim to study the costs and effects of a pro-active approach of migraine patients by the General Practitioner. The design is a pragmatic cluster randomised controlled trial with the general practice as the unit of randomisation. Patients using >=24 DDD's triptans are selected from the EMD and invited by mail to consult their GP. Diagnosis and treatment plan of migraine will be evaluated and discussed. Patients will be offered prophylactic treatment according to the Dutch Guidelines (NHG-standaard). The control group will receive usual care. The primary outcome is the score on the HIT-6 questionnaire.
Doel van het onderzoek
The aim of the study is to optimize therapy of migraine patients, according to the Dutch GP Guideline for headache and consequently reduce the use of triptans. The project will explore the costs and effects of a proactive approach of patients with triptan use by GPs.
Onderzoeksproduct en/of interventie
Proactive stepped approach based on the Dutch GP Guideline versus usual care. Step 1: a letter to invite patients for consultation. Step 2: a visit to the GP, who can give information about headache and therapy, reduce/stop the triptans, prescribe prophylactic therapy or reconsider the diagnosis of migraine.
Control group: care as usual.
Algemeen / deelnemers
Postzone V-0-P,
P.O. Box 9600
J.W. Blom
Leiden 2300 RC
The Netherlands
+31 (0)71 5268406
J.W.Blom@lumc.nl
Wetenschappers
Postzone V-0-P,
P.O. Box 9600
J.W. Blom
Leiden 2300 RC
The Netherlands
+31 (0)71 5268406
J.W.Blom@lumc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Patients in general practice using ¡Ý24 DDD triptans (or ¡Ý6 DDDs in the last 3 months), enlisted in 60 general practices, that are part of LEON (the Leiden Eerstelijns Onderzoeksnetwerk, managed by the department of Public Health and Primary Care).
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
1. Younger than 18 years;
2. Cognitive impairment;
3. Psychiatric illness;
4. Terminal illness;
5. Non-Dutch speaking.
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
| Register | ID |
|---|---|
| NTR-new | NL827 |
| NTR-old | NTR840 |
| Ander register | : N/A |
| ISRCTN | ISRCTN72421511 |